Havemeyer Place LP Makes New Investment in Agilent Technologies, Inc. $A

Havemeyer Place LP purchased a new position in Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 20,422 shares of the medical research company’s stock, valued at approximately $2,779,000. Agilent Technologies comprises about 0.5% of Havemeyer Place LP’s holdings, making the stock its 26th largest holding.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. 111 Capital acquired a new stake in shares of Agilent Technologies in the fourth quarter worth about $1,029,000. Lowe Brockenbrough & Co. Inc. acquired a new stake in shares of Agilent Technologies in the fourth quarter worth about $325,000. Pinebridge Investments LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter worth about $1,038,000. WINTON GROUP Ltd acquired a new stake in shares of Agilent Technologies in the fourth quarter worth about $396,000. Finally, Parallel Advisors LLC lifted its position in shares of Agilent Technologies by 6.2% in the fourth quarter. Parallel Advisors LLC now owns 6,733 shares of the medical research company’s stock worth $916,000 after buying an additional 393 shares during the last quarter.

Agilent Technologies Trading Down 2.1%

Agilent Technologies stock opened at $135.51 on Friday. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The business’s 50-day simple moving average is $118.35 and its 200-day simple moving average is $128.35. The firm has a market capitalization of $38.27 billion, a PE ratio of 27.21, a PEG ratio of 2.41 and a beta of 1.26. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the previous year, the company posted $1.31 earnings per share. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities research analysts forecast that Agilent Technologies, Inc. will post 5.99 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s payout ratio is currently 20.48%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Wolfe Research reaffirmed a “hold” rating on shares of Agilent Technologies in a research report on Tuesday, June 2nd. Royal Bank Of Canada initiated coverage on Agilent Technologies in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price objective on the stock. Bank of America upgraded Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their price objective for the stock from $150.00 to $145.00 in a research note on Thursday, May 28th. Robert W. Baird lifted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, Agilent Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $161.71.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.